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ABSTRACT
Objective: To evaluate the clinical outcome of  acute renal failure (ARF) patients when submitted to dialysis and non-dialysis treatments
in ICU. Methods: this prospective study included patients over 18 years of  age and serum creatinine of  >1.5 mg/dl. The patients were
included in dialysis and non-dialysis groups. Results: The study included 70 patients, 19 (27.1%) comprised the dialysis group and 51
(72.9%) the non-dialysis group. In the dialysis group, mortality rate was 42.1% and in the non-dialysis group was 33.3% (p<0.58).
Conclusion: There were multifactors of  ARF in ICU, but ARF is not the single cause for the high mortality rate in ICU patients.
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RESUMO
Objetivo: Avaliar a evolução clínica de pacientes com insuficiência renal aguda (IRA) submetidos a tratamento dialítico e não-dialítico na
UTI. Métodos: Estudo prospectivo onde foram incluídos pacientes com idade maior que 18 anos e com creatinina sérica > 1,5 mg/dl. Os
pacientes foram divididos em grupo dialítico e não-dialítico. Resultados: Dos 70 pacientes incluídos 19 (27,1%) foram do grupo dialítico
e 51 (72,9%) do grupo não-dialítico. A taxa de mortalidade foi de 42,1% no grupo dialítico e de 33,3% no grupo não-dialítico (p<0,58).
Conclusão: Há multifatores determinando a IRA na UTI, porém, não é causa isolada das elevadas taxas de mortalidade dos pacientes na
UTI.
Descritores: Insuficiência renal aguda/terapia; Insuficiência renal aguda /epidemiologia; Unidades de terapia intensiva; Enfermagem
RESUMEN
Objetivo: Evaluar la evolución clínica de pacientes con insuficiencia renal aguda (IRA) sometidos a tratamiento dialítico y no-dialítico en
la UCI. Métodos: Se trata de un estudio prospectivo donde fueron incluídos pacientes mayores de 18 años y con creatinina sérica > 1,5 mg/
dl. Los pacientes fueron divididos en grupo dialítico y no-dialítico. Resultados: De los 70 pacientes incluídos 19 (27,1%) fueron del grupo
dialítico y 51 (72,9%) del grupo no-dialítico. La tasa de mortalidad fue del 42,1% en el grupo dialítico y del 33,3% en el grupo no-dialítico
(p<0,58). Conclusion: Hay multifactores que determinan la IRA en la UCI, sin embargo, no es causa aislada de las elevadas tasas de
mortalidad de los pacientes en la UCI.
Descriptores: Insuficiencia renal aguda/terapia; Insuficiencia renal aguda/epidemiología; Unidades de cuidados intensivos; Enfermería
Corresponding Author: Lucienne Dalla Benardina
R. Napoleão de Barros, 754 - sala 110 - Vila Clementino - São Paulo - SP
Cep: 04024-002. E-mail: luciennedalla@hotmail.com
Reiceved article 15/03/2007 and accepted 10/10/2007
Acta Paul Enferm 2008;21(Número Especial):174-8.
* Original review elaborated from the masters degree thesis presented to the Nursing Department of  the Universidade Federal de São Paulo UNIFESP  São
Paulo (SP), Brazil.
1 MSc, Professor in the Faculdades Metropolitanas Unidas  FMU  São Paulo (SP), Brazil.
2 Adjunct Professor in the Nursing Department of  the Universidade Federal de São Paulo UNIFESP  São Paulo (SP), Brazil.
Acta Paul Enferm 2008;21(Número Especial):174-8.
175The clinical outcome of patients with acute renal failure in intensive care unit
INTRODUCTION
Acute renal failure (ARF) is characterized by the sudden
reduction of the Glomerular Filtration Rate, resulting in
the kidneys inability to exert the functions of  excretion,
maintaining the acid-basic equilibrium, and the organisms
hydroelectrolytic homeostasis. The ARF complications
significantly contribute with the elevation of the morbidity
and mortality rates in critical patients(1-2).
The incidence of ARF in hospitalized patients is 5%,
but in the Intensive Care Unit (ICU) its incidence varies
between 17% and 35%, and 49% to 70% of the patients
need dialysis treatment. The mortality rate varies between
50% and 90%, and is associated to extended
hospitalization time, the use of technologically advanced
therapies, type of ICU and population studied(3-6).
The main risk factors to the development of the ARF
in ICU are: ischemic, nephrotoxic, infectious, and
obstructive events, hypotension, shock (hypovolemic,
cardiogenic, and septic), cardiovascular, hepatic and
respiratory insufficiency, neoplasia and mean
hospitalization time greater than seven days(7-8). The
identification of  the ARF developments risk factors
directs the type of treatment , dialysis or non-dialysis(9).
Despite the technological advances, the increase in the
populations survival rate, and the therapeutic
improvement ARF remains one of the most frequent
complications found in ICUs. The combination of  risk
factors, clinical outcome, and the multiple interventions
in the ICU patient helped to upkeep the ARFs elevated
morbidity and mortality rates, without any significant
improvement for, at least, two decades(2-3,10).
Based on this information, the present study has the
purpose to evaluate the clinical outcome of ARF patients
subjected to dialysis and non-dialysis treatment in ICU.
METHODS
This prospective and observational study was
performed at a general ICU of  a private hospital in the
City of  São Paulo. The study took place between August
2002 and January 2003, with approval by the Ethics in
Research Committee of  the Federal São Paulo University
and by the Ethics Committee of the hospital in which
the research was performed. The data was collected from
the patients medical records, and written consent was
not necessary.
Patients (both genders)were included if they were older
than 18 years, and presented serum creatinine>1.5 mg/
dl at admission or along the hospitalization in ICU (11-
12). Patients were excluded if they had Chronic Renal
Insufficiency, were subjected to renal transplant and or
had been organ donors.
The collected variables were gender, age, co-morbidity,
hospitalization diagnosis in the ICU (clinical or surgical),
type of ARF (pre-renal, renal, post-renal), clinical and
surgical complications throughout ICU hospitalization,
type of  dialysis treatment, permanence time in the study,
ICU hospitalization time, laboratorial evaluation
(creatinine, urea, sodium, potassium) at the ARF onset
and when discharged from ICU, ICU patient destination
(discharge or death) and cause of death.
The Data collection was performed on a daily basis,
using the medical records. The patients were analyzed by
type of  treatment: dialysis and non-dialysis groups. The
type of treatment was chosen by the ICU medical staff
or by the nephrologist. The non-dialysis treatment was
characterized by volemic expansion, diuretic use,
vasoactive drug use, and aggressor agents removal. The
dialysis treatment consisted of the use of peritoneal dialysis
and hemodialysis. The non-dialysis patients that evolved
with little or lack of response to the treatment and needed
dialysis were included in the dialysis group.
The data collection was interrupted when the patient,
after the treatment, dialysis and non-dialysis, presented
creatinine less than or equal to 1.5 mg/dl, and this variable
is defined as the patient´s permanence time in the study.
The software used to analyze the statistical data was
the SPSS (Statistical Package for the Social Sciences), version
11.0 for Windows, employing the tests: Person chi-square
or the Fisher Exact Test, with a confidence interval of
95.0% (CI 95.0%); Students t Test for the independent
variables and Relative Risk (RR). In all tests, p<0.05 was
established to indicate statistical significance.
RESULTS
Along the data collection period, 759 patients were
admitted in the ICU. Of  those, 70 (9.2%) evolved with
ARF; 51 (72.9%) patients were included in the non-dialysis
group and 19 (27.1%) in the dialysis group. There was no
statically significant difference between groups concerning
gender, age, ICU hospitalization diagnosis, clinical or
surgical, and co-morbidity (Table 1).
The average co-morbidity by patient, shown in the
ICU admission was 2.1 in the dialysis group and 2.2 in
the non-dialysis group.
Table 2 displays the data regarding the patients
outcome in ICU. Renal ARF was greater (p<0.001) in
the dialysis group, compared to the non-dialysis type.
Along the ICU hospitalization, the patients showed
clinical or surgical complications associated to the ARF.
The pulmonary and metabolic complications were
statistically more frequent in the dialysis group, respectively
(p<0.03 and p<0.01). The permanence time in the study
and the hospitalization time in ICU were significantly
greater (p<0.004 and p<0.008) in the dialysis group.
Of  the 19 patients in the dialysis group, 15 (78.9%)
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were previously included in the non-dialysis group. In
the dialysis group, the renal replacement therapies used
by the patients were: 11 (50.0%) were treated with the
classic hemodialysis type (CHD), 7 (31.8%) with H
hemodiafiltration (HDF), 2 (9.1%) with intermittent
peritoneal dialysis (DPI) and 2 (9.1%) with continuous
ambulatory peritoneal dialysis (DPAC). Three (15.8%)
patients were subjected to more than one dialysis
treatment type; two had been treated first with DPI and
later with DPAC, and one (33.3%) patient was treated
first with HDF and later with HDC.
The mean initial creatinine for the dialysis group
was 4.6 md/dl, statistically greater (p<0.001) than for
the non-dialysis group (2.1 mg/dl). There was no
statistical difference in the values of urea, sodium and
potassium, for both groups. In the ICU discharge day,
the creatinine values were 3.6 mg/dl for the dialysis
group,  and 1.5 mg/dl for the non-dialysis
group(p<0.007).
Of the 11 (57.9%) patients of the dialysis group that
were discharged, three (27.3%) recovered the renal
function and eight (72.7%) had to remain on dialysis
techniques after discharge from ICU. In the non-dialysis
group, 34 (66.7%) patients received discharge from ICU,
19 (56.0%) of which evolved with creatinine less than
or equal to 1.5 mg/dl, and 15 (44.0%) patients with a
serum creatinine level greater than 1.5 mg/dl.
Regarding the patients mortality in ICU, 8 (42.1%)
patients from the dialysis group and 17 (33.3%) patients
from the non-dialysis group evolved to death, with no
statistical difference (p<0.58). The relative death risk for
the dialysis group was 26.0% greater than that for the
non-dialysis group (RR=1.26, IC 0.66 and 2.43). For
the dialysis group, the patient mortality rate in continuous
renal replacement treatment was statistically greater
(p<0.01) than in the intermittent treatment.
The cause of death in the dialysis group was: six
patients (75.0%), multiple organ failure; one patient
(12.5%), respiratory insufficiency, and one patient, sepsis.
In the non-dialysis group, six patients (35.3%), respiratory
insufficiency; six patients (35.3%), multiple organ failure;
two (11.7%), sepsis; one (5.9%), ARF; one (5.9%),
hemorrhagic vascular cerebral stroke, and one (5.9%),
cardiorespiratory insufficiency.
DISCUSSION
The lack of consensus about the definition of ARF
in ICU, the great diversity and complexity of  the
inclusion criteria in the study samples and, consequently,
the lack of results homogeneity complicates the
comparison with the literature. The many ARF definitions
and a lack of protocols for treatment optimization results
in countless ARF interventions(3,10).
The ARF is defined, in most studies, as when there is
Table 1  ARF patients characteristics from the dialysis
and non-dialysis groups, in ICUs admittance 
Characteristics 
Dialysis 
n = 19 
Non-Dialysis 
n = 51 
p 
Gender n % n %  
Male 15 78.9 34 66.7  
Female 4 21.1 17 33.3 0.32 
Age (years),X (± DP) 67+ 14+ 70+ 14+ 0.41 
ICU hospitalization 
diagnosis 
     
Clínical      
Pulmonary 7 36.8 22 43.1 0.78 
Cardiovascular 3 15.8 11 21.6 0.74 
Neurological 3 15.8 10 19.6 1.00 
Gastrointestinal 3 15.8 6 11.8 0.69 
Infectious 2 10.5 5 9.8 1.00 
Metabolic 1 5.3 1 2.0 0.47 
Surgical      
Gastrointestinal 2 10.5 7 13.7 1.00 
Cardiological 0 0 5 9.8 0.31 
Vascular 1 5.3 4 7.8 1.00 
Orthopedic 0 0 2 3.9 1.00 
Pulmonary 1 5.3 2 3.9 1.00 
Neurological 0 0 1 2.0 1.00 
Urologic 1 5.3 1 2.0 0.47 
Co-morbidity      
Cardiovascular 11 57.9 31 60.8 0.82 
Neoplasia 5 26.3 18 35.3 0.67 
Gastrointestinal 9 47.4 17 33.3 0.40 
Neurological 1 5.3 13 25.5 0.09 
Metabolic 7 36.8 12 23.5 0.36 
Pulmonary 4 21.0 10 19.6 1.00 
Other 4 21.0 14 27.4 0.76 
* Statistically significant for p<0.05
Table 2  ARF patients outcome, from dialysis and
non-dialysis groups, throughout ICU hospitalization.
 
Outcome 
 
Dialysis 
n = 19 
Nom-Dialysis 
n = 51 
p  
ARF Types n % n %  
Pre-renal 5 26.3 35 68.6  
Renal 14 73.7 15 29.4 0.001* 
Post-renal - - 1 2.0  
Complications n % n %  
Cardiovascular 17 89.5 43 84.3 0.71 
Infectious 7 36.8 18 35.3 1.00 
Pulmonary 12 63.2 17 33.3 0.03* 
Metabolic 12 63.2 14 27.4 0.01* 
Hematological 8 42.1 11 21.6 0.13 
Gastrointestinal 4 21.0 10 19.6 1.00 
Surgical Review  3 15.8 6 11.8 0.69 
Neurological 2 10.5 5 9.8 1.00 
Rhabdomyolysis - - 1 2.0 0.27 
Other 2 10.5 6 11.8 1.00 
 X± DP+ X± DP+  
Permanence Time 
in the Study (days) 20.6± 15.1+ 7.9+ 7.9+ 0.004* 
Hospitalization 
Time in ICU (days) 25.0± 17.1+ 10.8+ 10.8+ 0.008* 
Destiny n % n %  
Discharge 11 57.9 34 66.7 0.58 
Demise 8 42.1 17 33.3  
* Statistically significant for p<0.05
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elevation in the creatinine level between 1.3 mg/dl and
5.0 mg/dl, or when there is a need for dialysis treatment(8-
9,12-14). In this study, it was considered as serum creatinine
levels greater than 1.5 mg/dl(11-12).
When considering the samples characteristics
regarding male gender predominance, age and clinical
diagnosis in the ICU hospitalization, pulmonary and
cardiovascular diseases, the data was similar to that in
the literature(9,15-17).
The elevated number of co-morbidities by patient
can be explained by the great number of patients with
age greater than or equal to 65 years.
There is scarce information in the literature about
the analysis of relationships between co-morbidities and
acute renal failure. The studies show an association of a
determined co-morbidity that may or may not affect
the appearance of  ARF in ICU(8,11,17). In this study, the
restrictive factor located was the small number of co-
morbidities that, when grouped, did not allow to identify
them as a risk factor to ARF.
The occurrence of clinical and/or surgical
complications related to ARF was statistically greater for
the dialysis group. The need for using technologies and
therapeutic resources for these patients along their
treatment in ICU contributed to the elevated number
of complications(2-3).
In the moment of  the patients inclusion in the study,
the mean creatinine level for the dialysis group was
statistically greater. Taking into consideration the lower
limit of serum creatinine variation in both groups, it
was observed that the proximity of  these values to the
indication or decision of the medical conduct about the
definition of a dialysis or non-dialysis treatment.
Factors like the lack of  a concept definition for ARF,
its combination with preexisting diseases, nephrotoxic
therapeutic interventions, existence of  complications
during ICU hospitalization, and the intensive care
physicians  and/or the nephrologists experience are all
questionings that the literature has yet to answer, with
the objective of lowering the elevated mortality rates
of  ARF patients in ICU.
Many authors have been discussing about which is
the best dialysis modality for ARF patients in ICU.
However, there is still no consensus about which renal
replacement therapy would have the best results in ARF
treatment, i.e., mortality rates reduction, efficiency,
sessions frequency and clinical efficacy of the treatment
modality(10,18-19). The renal replacement therapies
alterations occurred according to the hemodynamic
stability, or not, of  the patients, and to the nephrologists
evaluation.
In the dialysis group, the patients mortality in the
continuous renal replacement therapy was statistically
greater than the mortality in the intermittent renal
replacement therapy. There is an inclination to use the
continuous renal replacement therapy over the
intermittent therapy, because of  the better hemodynamic
stability and better patients volemic, metabolic and
nutritional control(10). However, other authors,
comparing the results of this these two renal replacement
treatments, demonstrated an equal or lower survival rate
in patients subjected to continuous renal replacement
therapy(9,4,19).
The permanence time in the study and the
hospitalization time in ICU was statistically greater for
the dialysis group. Another study verified that the average
ICU hospitalization time was ten days for the non-dialysis
group and 15.2 days for the dialysis group, and was
statistically greater in the (p<0.003) for the dialysis group
as well(9). The majority of  the studies performed
comparisons between patients with and without ARF
in ICU, demonstrating an increase in ARF patients
hospitalization time(8,11,16).
In this study, there was no difference between the
morbidity rates for the dialysis and non-dialysis groups,
although the relative death risk had been greater for the
group subjected to dialysis treatment. The only study
that compares mortality rates between dialysis and non-
dialysis treatments found a greater mortality rate for the
dialysis patient group(9). Others studies analyzed surviving
or non-surviving patients regardless of  the type of
treatment(2,11,16).
The death causes in the non-dialysis group were
respiratory insufficiency and multiple organ failure.
In the non-dialysis group, multiple organ failure
prevailed. Another study analyzed the death cause
between ARF survivors and non-survivors, and
verified that multiple organ failure and sepsis were
the main causes(12).
CONCLUSION
In this study, there were fewer patients subjected to
dialysis treatment compared to patients subjected to non-
dialysis treatment. The co-morbidity indentified with
greater frequency in both groups was of cardiovascular
origin. The permanence time in study and the ICU
hospitalization time were significantly greater for the
dialysis group.
The events most frequently associated to ARF, for
both groups, were those of cardiovascular and infectious
nature, while the pulmonary and metabolic events
predominated in the non-dialysis group.
This studys results suggests that there are multiple
factors determining the critical patients outcome to ARF.
Thus, it seems that ARF is not, per se, the only factor
causing the high mortality rates that affect patients
hospitalized in ICU.
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